{"id":19567,"date":"2022-03-07T10:17:01","date_gmt":"2022-03-07T15:17:01","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19567"},"modified":"2022-03-07T10:17:02","modified_gmt":"2022-03-07T15:17:02","slug":"patients-divided-over-alzheimers-drug-is-it-a-risk-im-willing-to-take-or-just-a-magic-pill","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19567","title":{"rendered":"Patients Divided Over Alzheimer\u2019s Drug: Is It a \u2018Risk I\u2019m Willing to Take\u2019 or Just a \u2018Magic Pill\u2019?"},"content":{"rendered":"\n

(By Judith Graham for Kaiser Health News)<\/p>\n\n\n\n

If you listen to the nation\u2019s largest Alzheimer\u2019s disease advocacy organizations, you might think everyone living with Alzheimer\u2019s wants unfettered access to Aduhelm, a controversial new treatment.<\/p>\n\n\n\n

Opinions about Aduhelm (also known as aducanumab) in the dementia community are diverse, ranging from \u201cwe want the government to cover this drug\u201d to \u201cwe\u2019re concerned about this medication and think it should be studied further.\u201d Continue reading here…<\/a><\/p>\n\n\n\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n\n\n\n

\"\"<\/p>\n\n\n\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Judith Graham for Kaiser Health News) If you listen to the nation\u2019s largest Alzheimer\u2019s disease advocacy organizations, you might<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,32,31,6,15],"tags":[],"class_list":["post-19567","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-cms","category-fda","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19567"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19567\/revisions"}],"predecessor-version":[{"id":19568,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19567\/revisions\/19568"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}